ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617989 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617989; 2) Community: the network communities that were significantly associated with the response to NSC 617989; 3) Molecule: the relationships between components within communities and NSC 617989; 4) MDR: the compounds that were significantly associated with the NSC 617989.

NSC Compound Enrichment Correlation
NSC 685964 Null 0.0434721470609156 0.20425835
NSC 686551 Null 0.0434721470609156 0.38485257
NSC 689626 Null 0.0434721470609156 0.29181702
NSC 692303 2,3-Dihydro-3(R)-[4'hydroxyphenylsulfinyl]brefeldin A 0.0434721470609156 0.1100828
NSC 694619 Null 0.0434721470609156 0.2786822
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.0434721470609156 0.04073138
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.0434721470609156 0.0047196937
NSC 711077 Null 0.0434721470609156 0.19742143
NSC 718564 Null 0.0434721470609156 0.19509628
NSC 718781 Erlotinib hydrochloride 0.0434721470609156 -0.32768712
Total:184  Current:149    [First] [Prev] [Next] [Last]